Z
Zain Ahmed
Researcher at Cleveland Clinic Lerner College of Medicine
Publications - 5
Citations - 125
Zain Ahmed is an academic researcher from Cleveland Clinic Lerner College of Medicine. The author has contributed to research in topics: Immunology & In silico. The author has an hindex of 3, co-authored 4 publications receiving 101 citations. Previous affiliations of Zain Ahmed include Harvard University.
Papers
More filters
Journal ArticleDOI
Heart Transplantation: Challenges Facing the Field
TL;DR: Understanding why organs like kidneys and livers are prone to tolerance induction, whereas others like hearts and lungs are tolerance-resistant, could aid in attempts to achieve long-term, immunosuppression-free survival in human heart transplant recipients.
Journal ArticleDOI
Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma.
TL;DR: The combination of BRAF-targeted agents with immune checkpoint inhibitors represents a recent advance in the treatment of melanoma, even though each of these therapeutic approaches alone has specific limitations.
Journal ArticleDOI
Postoperative stereotactic radiosurgery for resected brain metastasis.
Zain Ahmed,Ehsan H. Balagamwala,Erin S. Murphy,Lilyana Angelov,John H. Suh,Simon S. Lo,Samuel T. Chao +6 more
TL;DR: The current literature exploring the efficacy and toxicity of postoperative SRS in the treatment of patients with resected brain metastasis is discussed.
Journal ArticleDOI
Identification of novel Plasmodium falciparum dihydroorotate dehydrogenase inhibitors for malaria using in silico studies
TL;DR: In this article , a computational screening comprising pharmacophore mapping, molecular docking, MM-GBSA calculations, ADME filtering and molecular dynamics were performed in order to identify novel and powerful PfDHODH inhibitors.
Book ChapterDOI
Combination BRAF-Directed Therapy and Immunotherapy
TL;DR: This chapter focuses on the limitations of each of these strategies as monotherapy, and the rationale for combining these therapies, as well as considerations and future directions for therapy.